Conversion back to bevacizumab or ranibizumab for recurrent...

Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series

Slean, Geraldine R., Hemarat, Kornwipa, Khurana, Rahul N., Stewart, Jay M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Language:
english
Journal:
International Journal of Retina and Vitreous
DOI:
10.1186/s40942-016-0028-9
Date:
December, 2016
File:
PDF, 790 KB
english, 2016
Conversion to is in progress
Conversion to is failed